Zebra Technologies

Phase A — Understand the business

Lens 1 · Company Overview

Zebra is the global leader in Automatic Identification and Data Capture (AIDC) — the unglamorous, mission-critical plumbing that lets a warehouse, store, hospital, or parcel network know what an object is, where it is, and what to do with it. The product spine: rugged mobile computers, barcode scanners/imagers, RFID readers, thermal label/card printers, supplies (labels, ribbons, RFID tags), real-time location systems, machine vision, plus attached services and cloud software.

Scale: 129 facilities, ~10,700 employees, sales in 179 countries through 10,000+ channel partners. FY2025 net sales $5,396M, market cap ~$11B at $245.69 (2026-06-22).

Revenue model: ~82% tangible products ($4,418M of $5,396M FY2025), ~18% services & software ($978M). Despite heavy "frontline AI / software companion" marketing language in the 10-K, this is still fundamentally a hardware company — the software/services mix has barely moved (services & software was $965M in FY2024, $919M in FY2023). Recurring revenue is real but small; remaining performance obligations (RPO) totaled $1.15B at Q1 FY2026, recognized over ~2 years.

Segments (reorganized Q4 2025):

• Connected Frontline (CF) — mobile computing + Elo touchscreens/kiosks + workflow software + related services. FY2025 $2,960M.
• Asset Visibility and Automation (AVA) — barcode/card printing, supplies & sensors, data capture, fixed industrial scanning, machine vision, RFID/RTLS, related services. FY2025 $2,436M.

Contract structure: two-tier distribution. Three distributors each >10% of net sales: Customer A 29%, B 15%, C 15% → ~59% of revenue through three counterparties. This is sell-in to distribution, not direct end-demand — a recurring source of channel-inventory whip (the 2023 demand air-pocket was exactly this).

Lens 2 · Supply Chain

Map: silicon & components (sole/limited-source suppliers, many in China) → EMS/JDM contract manufacturers (China, Malaysia, Vietnam, Taiwan, Mexico) → Zebra-controlled distribution centers / 3PLs → two-tier distributors (Customer A/B/C) → VARs/ISVs/OEMs → end-users (retail, T&L, manufacturing, healthcare, public sector).

Named stakeholders:

• Downstream buyers (distributors): three unnamed distributors at 29/15/15% of sales. Industry knowledge places these as the big AIDC distributors (ScanSource, BlueStar, Ingram-type channels) but the filing does not name them — n/a — not named in filing.
• Contract manufacturing: outsourced to EMS/JDMs; Zebra retains supplier selection + key-component price negotiation but the EMS buys the components.
• Supplies/sensors produced in-house in US, Mexico, Europe, supplemented by Asia-Pacific third parties.

Chokepoints / single-source risk: the 10-K explicitly flags sole-source components and multi-year, non-cancellable purchase commitments (~$101M, primarily semiconductors and cloud) that must be honored even if demand falls — the mechanism that turned the 2022-23 over-order into excess inventory. Tariff exposure is the live chokepoint: the Asia-heavy manufacturing base meant Zebra paid ~$75M in IEEPA import tariffs in 2025. Supply-chain map carried with `` grounding; commercial-layer kb/robotics/wiki/supply-chain.md is the robotics supply chain and is not applicable to an AIDC company — do not cross-cite it.

Lens 3 · Competitive Advantages (moats)

Zebra's moat is distribution + installed base + switching costs, not technology leadership:

1. Largest installed base in AIDC — drives a high-margin attach annuity (supplies, services, accessories, software) that competitors can't easily contest.
2. 10,000+ channel partner network across 179 countries — the company itself names this as the hardest thing for a new entrant to replicate. Real, but it is also the source of the customer-concentration risk (Lens 13).
3. Switching costs — purpose-built devices deployed with specialized software, fleet-management (device lifecycle), and multi-year service agreements; a fleet swap is an operational project, not a purchase.
4. Scale economics in R&D ($593M, 11.0% of sales) and global service/repair footprint.

Bargaining power: strong over fragmented supplies competitors; weak over its top distributors (one customer at 29% has leverage); moderate over end-users given switching costs. This is a durable mid-grade moat — wide enough to defend share and margins through cycles, not wide enough to compound revenue at tech-multiple rates. Web view concurs the moat is "narrow-to-moderate".

Lens 4 · Segments

All segment figures ``.

Q1 FY2026:

The single most important segment fact: the headline growth is mostly bought, not earned. CF's +20.6% Q1 print is +3.8% organic — 14.7pts was the Elo acquisition and ~2pts FX. AVA +7.4% reported is +4.8% organic. So the real underlying business is growing mid-single-digits, consistent with a mature, share-stable AIDC franchise in a cyclical recovery off the 2023 trough. AVA is the higher-quality segment (50%+ gross margin, expanding on mix/productivity); CF carries lower hardware margins but is where the AI/software narrative lives. Geography (Q1'26): North America $728M (49%), EMEA $507M (34%), APAC $167M (11%), LatAm $93M (6%).

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest print — Q1 FY2026, reported 2026-05-12)

• Revenue $1,495M, +14.3% YoY; beat consensus.
• GAAP operating income $215M (14.4% margin), +10.3%; GAAP net income $135M vs $136M — flat YoY; GAAP diluted EPS $2.72 vs $2.62.
• Non-GAAP diluted EPS $4.75, +18%; adjusted EBITDA $347M = 23.2% margin, ~9% above forecast.
• Drivers: mobile computing + Elo in CF; printing, RFID, machine vision in AVA; management framed demand as "broad-based" with AI/RFID/machine-vision tailwinds.
• Margins: consolidated GM 49.6% (+30bps); AVA GM 51.9% (+130bps) on mix/FX/productivity; CF GM 49.1% (+40bps).
• Tone shift — guidance RAISED: FY2026 sales growth lifted to +10-14%, adj EBITDA margin ~22%, non-GAAP EPS $18.30-$18.70 (above ~$18.09 consensus). Q2'26 guide: sales +14-17%, adj EBITDA ~21%+, non-GAAP EPS $4.20-$4.50.
• Balance-sheet flags: Q1 FCF $163M (+$5M YoY); effective tax rate rose to 19.2% (from 17.6%); other expense up on realized losses from selling long-term investments + lower interest income.
• The unusual line vs its own history: GAAP net income was flat on +14% revenue. The gap between the +18% non-GAAP EPS and 0% GAAP net income growth is the entire story — below-the-line items (amortization, SBC, tax, FX, restructuring) are absorbing the operating gains.
• Market reaction: stock surged on the beat + raise, yet still sits at ~$245 (down ~34% from 2024 highs through the 2025 tariff scare ).

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on the shelf (transcripts/ empty) — `` only.

• Q1 FY2026 (May 2026): most upbeat call in the cycle — "healthy backlog and pipeline," Elo momentum, guidance raised, RFID/machine-vision/AI repeatedly cited as growth vectors.
• Arc since 2023: the through-line is recovery → confidence. 2023 calls were defensive (channel destocking, demand air-pocket, cost cuts); 2024 calls turned to "demand stabilizing/recovering"; 2025 calls pivoted to tariff-management + portfolio-sharpening (exiting robotics, Elo integration); Q1'26 is offense ("highest-growth opportunities").
• What they stopped saying: the heavy "robotics / Fetch / autonomous mobile robots" language of 2021-22 is gone — replaced by RFID, machine vision, and "AI for the frontline." That linguistic shift is the strategy pivot, confirmed by the divestiture.
• Recurring phrases: "digitize and automate frontline workflows," "asset visibility," "disciplined capital allocation."

Lens 7 · Comps

Multiples `` with date, or n/a. ZBRA forward P/E computed on the midpoint of its own non-GAAP guidance.

Read: ZBRA at ~13x forward non-GAAP EPS is by far the cheapest name in its competitive set — Cognex (~34x) and Keyence (~46x) carry pure-play machine-vision/automation premiums; even diversified Honeywell (~21x) is richer. The market is valuing Zebra as a low-growth, cyclical, hardware-concentrated industrial, not as the "frontline AI" platform its decks describe. Whether that gap is a value opportunity or a correct discount for ~4% organic growth + customer concentration is the central debate. ROE/ROIC and EV multiples for ZBRA itself were not cleanly sourceable from the searches — flagged rather than fabricated. (For orientation only: FY2025 net income $419M on equity $3,588M ≈ 11.7% GAAP ROE.)

Lens 8 · Stock-Price Catalysts (>5% moves, last ~5 years) — /

• 2021-22 (down ~60% peak-to-trough): post-pandemic demand normalization + rate shock de-rated all hardware multiples. The $290M Fetch Robotics buy (2021) was top-of-cycle capital allocation.
• 2023 (sharp drops on guidance cuts): channel destocking and a demand air-pocket; revenue fell to $4,584M FY2023 (op income $481M).
• 2024 (recovery): demand stabilized mid-2024; FY2024 revenue +8.7% to $4,981M, net income $528M / $10.18 EPS.
• 2025 (down ~34% on tariffs): new US tariffs hit the Asia manufacturing base; the stock de-rated to ~13x FCF even as Q1'25 earnings rose 42%.
• Feb 2026: SCOTUS invalidated IEEPA tariffs → potential $75M refund claim — a positive catalyst not yet in the numbers.
• Apr 2026: Skild AI robotics divestiture announced.
• May 2026: Q1 beat + raised guidance → stock surged.

Pattern: ZBRA is a cyclical demand + macro/tariff name first, an execution name second. The tape reacts hardest to (a) enterprise hardware demand inflections and channel inventory, and (b) trade/tariff policy — not to software/AI narrative. Earnings beats matter but the multiple is governed by the demand cycle and the China-tariff overhang.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO Bill Burns (since March 2023; prior Chief Product & Solutions Officer at Zebra; 30+ yrs tech, two prior CEO roles). CFO Nathan Winters. Avg management tenure ~5.3 yrs, board ~5.6 yrs.
• Track record: Burns's team navigated the brutal 2023 destock and ran a multi-year cost-restructuring (2024-25 productivity plans), returning the business to ~13% operating margin and record revenue. Credible operational execution through a hard cycle.
• Skin in the game / capital allocation — mixed-to-good:
• Buybacks aggressive: $587M repurchased FY2025; $300M in Q1'26 + $200M more in Q2'26; a new $1B authorization (Feb 4, 2026). Buying back ~13x-earnings stock is sensible capital allocation. No dividend.
• M&A — the blemish: the Fetch Robotics round-trip is value destruction — bought for $290M (2021), sold for ~$20M total consideration + Skild equity (2026). A ~$270M cash impairment of a top-of-cycle deal. Offsetting it, the Elo acquisition ($1,303M, Sept 2025) is already accretive to growth and is the engine behind CF's reported numbers; Photoneo ($62M, Feb 2025) bolsters machine vision. So the recent M&A scorecard is: one clear miss (Fetch), one large bet still being proven (Elo), one small sensible tuck-in (Photoneo).
• Red flags: SBC stepped up in FY2025 (management changed the timing/eligibility of the annual grant, inflating the year's expense and the GAAP/non-GAAP gap) — watch this. No related-party or promotional-behavior flags surfaced.
• Archetype: professional managers (not founders), appropriate for a mature franchise being run for margin, cash, and disciplined capital return — the right operators for this stage, but not visionaries who will conjure a growth re-rate on their own.

Lens 10 · Forensic Red Flags

Forensic equity-analyst lens. Figures `` unless noted.

1. Goodwill > equity — the headline flag. Goodwill $4,727M + other intangibles $809M = $5,536M, ~65% of total assets ($8,502M) and more than total stockholders' equity ($3,588M). Goodwill jumped $836M in FY2025 (Elo/Photoneo). Tangible book is negative. Any future demand shock that forces a reporting-unit impairment would hit equity hard. Annual test (Q4 2025) passed, and a $45M impairment was already taken in FY2025 (the robotics exit: $34M intangible + $8M lease + $3M PP&E). The goodwill load is the single biggest balance-sheet risk.
2. GAAP vs non-GAAP gap is wide and widening. FY2025 GAAP EPS $8.18 vs an implied non-GAAP run-rate well above it; Q1'26 GAAP EPS $2.72 vs non-GAAP $4.75 — a ~$2.03/quarter (~43%) add-back for amortization, SBC, restructuring, acquisition costs. Management guides and the Street values on the $18.30-$18.70 non-GAAP number, which excludes real, recurring economic costs (SBC especially). The "13x" multiple is on adjusted earnings; on GAAP it is far higher. Discipline check: GAAP net income was flat YoY on +14% revenue.
3. Tax-rate volatility. Effective tax rate swung from 16.9% (FY24) to 25.2% (FY25) to 19.2% (Q1'26) — multinational tax (US/UK/Singapore) is the auditor's Critical Audit Matter. EPS comparability is muddied by tax, not just operations.
4. Working capital vs revenue. AR $801M (up from $692M) and inventory $729M (up from $693M) both grew faster than revenue in FY2025 — partly Elo consolidation, but worth watching for channel-stuffing/inventory-build given the distributor concentration. Allowance for doubtful accounts is a thin $1M.
5. Cash conversion. FY2025 GAAP net income $419M vs CFO $917M — cash flow comfortably exceeds earnings (D&A + working-capital release), which is reassuring, not a flag. FCF $831M. The flag is the other direction: only $125M cash on hand against $2,511M debt.
6. Leverage + variable-rate exposure. Total debt $2,511M, of which ~$2.0B is floating-rate (SOFR); a 1pt rate move = ~$20M annual interest. Net debt ~$2.4B (~2.3x FY25 adj EBITDA of ~$1.05B+ ) — manageable but not trivial given the Elo-funded revolver draw.

Regulatory findings (required):

• SEC: No Litigation Releases or AAERs naming Zebra in the 2021-2026 window.
• 10-K Item 3 / 10-Q contingencies: ordinary-course IP, employment, tort, and contract matters only; management states outcomes are not expected to be material. The 10-K flags generic FCPA/UK Bribery Act exposure as a category risk, with no active matter disclosed.
• Non-SEC enforcement (web): no material FTC/DOJ/FDA/CFPB enforcement actions, consent decrees, or fines surfaced for Zebra Technologies. The one material government-action item is a favorable one: the SCOTUS IEEPA tariff invalidation → Zebra's $75M refund claim.
• Verdict: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K Item 3 / 10-Q contingencies as of 2026-06-23.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection (FY2026 / FY2027 / FY2028 — non-GAAP EPS)

Built bottom-up from FY2025 actuals + Q1'26 + management guidance. Base anchored on management's own FY2026 guide ($18.30-$18.70 non-GAAP, +10-14% sales, ~22% adj EBITDA margin); FY2027-28 are `` with arithmetic shown. Note: these are non-GAAP EPS (the number the Street and management use); GAAP will run materially lower due to ~$2/qtr add-backs.

Key input lines (all labeled): FY2026 organic growth ~4-5%; Elo carryover adds ~5-6pts to reported H1; adj EBITDA margin ~22%; FY2026 capex $85-95M; share count shrinking on $1B buyback at ~13x; tariff refund $75M is upside-not-in-base. The base case is essentially "management hits its guide, then the business reverts to its structural mid-single-digit organic algorithm, with buybacks doing the heavy lifting on EPS."

Forecast tracker (forecast.ts create) intentionally SKIPPED — unattended --watchlist rule (log a Brier forecast only on genuine committed conviction, via a human-gated /thesis pass).

Lens 12 · Bull vs Bear

Bull case. Zebra is the dominant, sticky, cash-generative leader of an essential infrastructure category that every warehouse/store/hospital needs, trading at ~13x forward earnings with no dividend drag and a fresh $1B buyback — a rare value multiple for a #1 franchise with 48-50% gross margins. The cycle is inflecting up (Q1 demand "broad-based," guidance raised); Elo opens a new self-service/kiosk TAM; RFID and machine vision are secular share-gainers; the $75M tariff refund is free upside; and management has proven it can cut costs and return cash. If the market ever re-rates this from "cyclical hardware" toward even a 16-18x multiple, that alone is +25-40% — and that is precisely what the Street's $330 median target (range $281-$400) assumes.

Bear case (permanent-impairment risks).

1. It's a hardware company priced as a platform — and the platform isn't materializing. Software/services is stuck at ~18% of revenue and barely growing; organic growth is ~4%. The "frontline AI" story is a re-rating thesis with no organic-acceleration evidence yet.
2. Customer + China concentration. 59% of revenue through three distributors; Asia-concentrated manufacturing exposes the whole P&L to tariff/trade-policy shocks (the 2025 de-rate, the $75M paid, the refund still uncertain).
3. Goodwill > equity. $5.5B intangibles vs $3.6B equity — a demand shock forces impairments and a balance-sheet hit; the Fetch round-trip proves the M&A engine can destroy capital top-of-cycle.

Pre-mortem (18 months out, thesis broke): Enterprise IT hardware budgets tighten into a 2027 slowdown; distributors destock again (a repeat of 2023); Elo's growth contribution laps out and reveals organic CF flat; a tariff regime returns post-remand; a goodwill impairment lands. The stock that looked "cheap at 13x" turns out to have been correctly priced for ~4% growth + cyclicality, and the multiple compresses rather than expands.

Are multiples too high? No — if anything ZBRA's own multiple is low. The risk isn't a multiple that's too high; it's that the low multiple is deserved and won't re-rate.

Contrarian view (what the market refuses to see): The market is anchored on "boring cyclical hardware" and is ignoring the embedded Skild AI equity stake — Zebra took equity in a robotics-foundation-model company that raised $1.4B at a >$14B valuation in Jan 2026. Zebra effectively swapped a cash-bleeding owned-robotics business for a free call option on the AI-robotics winner plus it remains the orchestration/RFID/vision layer those robots will need. The bull-bull case is that Zebra is the "picks-and-shovels of embodied AI in the warehouse" at 13x earnings — but that requires the Skild bet to pay off, which is unprovable today.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case.

• Structural break: Zebra's economics hinge on enterprise hardware refresh cycles (Wi-Fi 7, 5G, Android transitions). If smartphones/tablets + cheaper Asian rivals (Urovo, Newland, Chainway) commoditize rugged mobile computing, CF — the larger segment — faces price erosion. The moat is distribution, and distribution moats erode slowly but permanently.
• Revenue concentration: Customer A at 29% and rising (from 18% in 2023). If that distributor consolidates, in-sources, or shifts allocation, a quarter detonates. This is the most dangerous single line in the filing.
• Most dangerous competitor bulls underestimate: not Honeywell (also struggling in this segment) — it's Keyence and Cognex in machine vision (where Zebra is sub-scale despite Photoneo) and Impinj in RFID silicon (Zebra buys/competes at the reader/system layer, not the chip — it doesn't own the RFID value chain's highest-margin node). Zebra is a generalist surrounded by sharper specialists in its two "growth" vectors.
• Worst capital allocation: Fetch Robotics — ~$290M in, ~$20M out. A ~93% capital loss on a marquee acquisition. It validates the bear worry that management chases narratives at cycle tops (and raises the question of whether Elo at $1.3B is the next one).
• Assumptions that must hold for $245: ~4-5% organic growth persisting, no distributor defection, no tariff re-imposition, Elo synergies real, no goodwill impairment. If growth disappoints 20-30% (organic goes flat/negative in a 2027 slowdown), non-GAAP EPS likely re-rates toward the bear ~$17 and the multiple compresses — a double hit that could take the stock back toward the $160-180 it saw in the 2025 tariff trough.
• Single scenario that permanently impairs: a structural shift of rugged enterprise computing to commodity Android devices + Asian OEMs, collapsing CF gross margins and forcing a multi-billion goodwill write-down. Plausibility: low-to-moderate over 3 years (switching costs are real), but non-trivial over 5-10.

Lens 14 · Management Questions (ordered by information value)

1. CF reported +20.6% but +3.8% organic in Q1 — what is the organic CF growth you expect once Elo laps out in H2 2026, and is the underlying mobile-computing business growing at all ex-acquisition?
2. Customer A is now 29% of net sales (up from 18% in 2023). What is the contractual stickiness, and what is your contingency if that distributor reallocates or in-sources?
3. You took a ~$270M loss on Fetch Robotics. What changed in your M&A underwriting, and how is Elo ($1.3B) being underwritten differently to avoid a repeat?
4. Describe the Skild AI equity stake — size, carrying value, governance rights — and how you think about Zebra's role in the embodied-AI/warehouse-orchestration stack now that you've exited owned robotics.
5. Goodwill + intangibles ($5.5B) exceed equity ($3.6B). Under what demand scenario do your reporting units fail the impairment test, and how much cushion exists today?
6. The gap between non-GAAP ($4.75) and GAAP ($2.72) EPS is ~43%, driven partly by a step-up in SBC. Walk through the FY2026 SBC trajectory and why investors should value the add-back-adjusted number.
7. On the $75M IEEPA tariff refund — what is your base-case timing and probability of recovery, and is any of it in the FY2026 guide?
8. What percentage of COGS is sourced from China today, and what is the multi-year plan (Mexico/Vietnam/Malaysia) to de-risk the tariff exposure that de-rated the stock in 2025?
9. Services & software has been stuck near 18% of revenue for three years. What is the concrete plan and timeline to make recurring revenue a structurally larger mix?
10. Where is Zebra sub-scale in machine vision vs Keyence/Cognex, and does Photoneo close that gap or do you need more M&A?
11. RFID is cited as a growth driver, yet Impinj owns the chip. Where does Zebra capture durable margin in the RFID value chain versus reselling others' silicon?
12. The 2025 Productivity Plan targets ~$35M annualized savings. Is that the end of restructuring, or should we model further charges into 2027?
13. With ~$2.0B of floating-rate debt, what is your appetite for swaps/refinancing, and what rate path is embedded in your interest-expense guidance?
14. With only $125M cash and a $1B buyback authorization, how do you prioritize buybacks vs. debt paydown vs. the next acquisition over the next 18 months?
15. What would have to be true for Zebra to grow organic revenue at high-single-digits sustainably — and is that even the goal, or is this a margin-and-capital-return story?

---